Use of bio-banks in the EurocanPlatform
18 May 2012
Use of bio-banks in the EurocanPlatform
New approaches to personalised medicine
Recent developments in neoadjuvant therapy
Highlights and goals of IMPAKT 2012
PI3K and the heterogeneity of small tumour breast cancer
Molecularly characterising triple negative breast cancer
Endocrine therapy and endocrine resistant breast cancer
Neoadjuvant therapy and PCR through chemotherapy prior to surgery
Minimising recurrence by using most effective treatment
Overcoming drug resistance and targeting critical pathways
Heterogeneity of tumours and the challenges of biomarker development
Targeting the PI3K/mTOR pathway